Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

国药瑞福莱药业有限公司成立于1993年,于2012年3月混改后,正式更名为“国药瑞福莱”,是由嘉兴琨玉投资合伙企业(有限合伙)、中国医药投资有限公司和北京大成协作医疗科技发展有限公司共同投资,公司是集医药研发、生产、销售于一体的国有股份制企业。作为中国医药集团高新技术制剂产品孵化基地,国药瑞福莱专注于控释透皮技术的研发和产业化。作为中国*大的透皮贴剂产品供应商,国药瑞福莱始终遵循专业化的发展方向,致力于打造国内*强的透皮贴剂研发及产业化基地。公司上市的所有品种均由企业自主开发、国内急需的高效特效药物,不但在国内处于领先水平,在国际上也处于领先地位,投放市场后得到了医生和患者的广泛赞誉和欢迎。其中“小贴士”为国家一类新药,是山西省获得的*国家一类新药。另有5个透皮贴剂新品取得临床研究批件,并已展开临床研究,这将使得中国患者早日应用到世界*先进的药品。公司拥有亚洲首条由国外引进的全自动贴剂生产线,并配备先进检测仪器和设备,引进国际先进药品生产管理体系、生产技术,严格按照GMP标准进行生产管理,是山西省太原市首家获得非无菌制剂GMP证书的企业。公司将继续以“透皮贴剂”做为重点开发项目,秉承坚韧不拔的创业精神、锐意进取的创新精神,在市场经济的大潮中乘风破浪、勇往直前,续写辉煌的新篇!公司现正在第七个五年发展计划中,励志未来5-10年进行资本上市,经过多年的厚积薄发,经营业绩逐年上升,员工薪酬福利稳步提升。现因业务发展需要,诚邀各界英才加盟,共谋大业。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (4 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 93%
  • 2024: Up 2600%
  • 2023: Flat 0%-
  • 2022: Down 50%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 国药瑞福莱药业有限公司 growing? 2025: 52 openings (up 93%), 2024: 27 openings (up 2600%), 2023: 1 openings (flat), 2022: 1 openings (down 50%), 2021: 2 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (18 records)

Manage
salary range: 3K - 15K, 100% of roles pay ¥3-15K
Note: salary statistics are based on 18 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 国药瑞福莱药业有限公司?100% of positions earn 3-15K, Undergraduate salary: ¥。销售类 average salary ¥8.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 销售类
    33.3% of total 33.3%
  • 工厂生产类
    22.2% of total 22.2%
  • 市场/公关/媒介类
    22.2% of total 22.2%
  • 客户服务类
    16.7% of total 16.7%

Education

  • 本科
    72.2% of total 72.2%
  • 大专
    22.2% of total 22.2%
  • 高中
    5.6% of total 5.6%

Experience

  • 1-3年
    44.4% of total 44.4%
  • 3-5年
    22.2% of total 22.2%
  • 不限
    22.2% of total 22.2%
  • 5-10年
    11.1% of total 11.1%
View Detailed Analysis

What does 国药瑞福莱药业有限公司 require? Who is 国药瑞福莱药业有限公司 hiring? recruitment: 销售类占比最多占33.3%,其次是工厂生产类占22.2%. What education can get in at ? 本科占比最多占72.2%,其次是大专占22.2%. Work experience required at ? 1-3年占比最多占44.4%,其次是3-5年占22.2%. Where are the job locations at ? 太原占比最多占77.8%,其次是北京占11.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 25,397.1429万(元)
Legal Representative: 沈扬
Date Established:
Credit Code: 91140100590886912K
Registered Address: 山西转型综合改革示范区唐槐产业园医药园19号

People who follow this company also follow

Competitors (Similar Companies)

医药分销 医药供应链 药品零售 医药配送
服务外包 安防工程 安防 系统集成
新特药 医药流通 药品零售 医药营销
制药/药业 生产 医药 实业投资
生物科技/生物工程 医药 生产 研发
出版社 出版 数字图书馆 出版发行
抗生素 心血管药 药品零售 化学制药
食品 饮料 调味品 醋饮料
电池 电池材料 离子电池 充电电池
“Innovative drug R&D”
医药 药物研发 生物实验 创新药
制药/药业 生产 丸剂 冲剂
“功能性生物蛋白产品研发商”
“Trustworthy biological experiment service provider”
“Helping partners successfully develop new drugs, reducing R&D costs an”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates